More Questionable Stem-Cell Science

Disgraced stem-cell researcher Hisashi Moriguchi has published three new papers in BMJ Case Reports, including a rehashing of a retracted 2012 paper.

Written byChris Palmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Tokyo Medical and Dental UniversityWikimedia Commons, Rs1421Hisashi Moriguchi is at it again. The researcher, who last year confessed to falsifying stem-cell findings in a number of published papers, has published three new studies over the past 2 months in the peer-reviewed medical journal BMJ Case Reports, Nature reported last week.

In October 2012, a Nature investigation brought to light the fraudulent nature of Moriguchi’s work, including descriptions of six heart disease patients who had experienced significant therapeutic improvement after receiving injections of cardiac muscle cells derived from induced pluripotent stem cells (iPSCs) in their hearts. Moriguchi subsequently admitted that his claims were false, leading to his dismissal from the University of Tokyo and the retraction of several papers.

Now, Moriguchi, who has a degree in nursing and a master’s in health promotion, but no formal training in molecular biology, has three new papers out in BMJ Case Reports. One paper, published online in April, describes a procedure for supercooling oocytes to preserve eggs from the ovaries of cancer patients for future in vitro fertilization procedures. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies